Skip to main content
SHWZ
OTC Life Sciences

Schwazze Completes Major Asset Sale: 45 Dispensaries, 2 Facilities Acquired by Vireo Growth

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Healthcare
Sentiment info
Neutral
Importance info
9
Price
$0
Mkt Cap
$78
52W Low
$0
52W High
$0.25
52W Position info
0.0% above low
Off High info
100% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

SHWZ is trading near its 52-week low of $0 (0.0% above the low) on light trading volume (0.1× avg).

Summary

Vireo Growth Inc. has announced the closing of its acquisition of significant assets from Schwazze (Medicine Man Technologies, Inc.). The transaction includes 45 dispensaries (24 in Colorado, 21 in New Mexico) and two manufacturing facilities (one in each state). For Schwazze, this represents a substantial divestiture of its operational footprint, fundamentally altering its business scope. Given SHWZ's extremely low market capitalization and stock price, this asset sale is highly material and likely indicates a significant strategic shift or restructuring for the company. Investors will need to assess the remaining assets and strategic direction of Schwazze following this substantial divestiture.

At the time of this announcement, SHWZ was trading at $0.00 on OTC in the Life Sciences sector, with a market capitalization of approximately $78. The 52-week trading range was $0.00 to $0.25. This news item was assessed with neutral market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

SHWZ - Latest Insights